Synapse Open Synapse
Biology

Beam’s base editing therapy for sickle cell hits goal in pivotal trial

BioPharma Dive · · 2 min read

The result represents a scientific milestone and positions Beam to submit a first-of-its-kind FDA application as soon as the end of the year.

Latest from BioPharma Dive